Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
12.4M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
22.7M
-
Shares change
-
-4.25M
-
Total reported value, excl. options
-
$24M
-
Value change
-
-$5.76M
-
Number of buys
-
22
-
Number of sells
-
-20
-
Price
-
$1.06
Significant Holders of P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share (PIII) as of Q1 2023
52 filings reported holding PIII - P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share as of Q1 2023.
P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share (PIII) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.7M shares
.
Largest 10 shareholders include FMR LLC (6.66M shares), JANUS HENDERSON GROUP PLC (5.68M shares), AMERIPRISE FINANCIAL INC (3.15M shares), VANGUARD GROUP INC (1.84M shares), BlackRock Inc. (1.58M shares), Alyeska Investment Group, L.P. (1M shares), EMFO, LLC (657K shares), GEODE CAPITAL MANAGEMENT, LLC (520K shares), STATE STREET CORP (366K shares), and NORTHERN TRUST CORP (196K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.